Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation

NCT01266369 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Mastocytosis

Interventions

DRUG: masitinib

Sponsor

AB Science